ProfileGDS4718 / 229466_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 63% 59% 55% 63% 63% 57% 61% 61% 72% 62% 61% 68% 58% 63% 57% 59% 63% 54% 63% 65% 58% 61% 66% 61% 60% 60% 65% 68% 64% 61% 58% 55% 64% 59% 62% 59% 64% 58% 62% 56% 65% 64% 59% 58% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.3628863
GSM549102patient 115, normal, homogenized [OPG study]6.0396859
GSM549104patient 119, normal, homogenized [OPG study]5.8002455
GSM549108patient 138, normal, homogenized [OPG study]6.3465463
GSM549119patient 077, normal, homogenized [OPG study]6.3026263
GSM549133patient 032, cancer, homogenized [OPG study]5.9031257
GSM549139patient 042, cancer, homogenized [OPG study]6.1767161
GSM549099patient 107, normal, homogenized [OPG study]6.1782661
GSM549109patient 139, normal, homogenized [OPG study]6.981172
GSM549110patient 046, normal, homogenized [OPG study]6.2359662
GSM549114patient 063, normal, homogenized [OPG study]6.1449661
GSM549122patient 082, normal, homogenized [OPG study]6.6979768
GSM549134patient 033, cancer, homogenized [OPG study]5.975658
GSM549136patient 036, cancer, homogenized [OPG study]6.2911663
GSM549140patient 044, cancer, homogenized [OPG study]5.9302857
GSM549111patient 047, normal, homogenized [OPG study]6.0806759
GSM549113patient 057, normal, homogenized [OPG study]6.2889263
GSM549132patient 031, cancer, homogenized [OPG study]5.7501254
GSM549137patient 038, cancer, homogenized [OPG study]6.3633963
GSM549142patient 047, cancer, homogenized [OPG study]6.5071465
GSM549100patient 110, normal, homogenized [OPG study]5.969358
GSM549107patient 135, normal, homogenized [OPG study]6.162161
GSM549115patient 068, normal, homogenized [OPG study]6.5895266
GSM549116patient 072, normal, homogenized [OPG study]6.1642361
GSM549120patient 078, normal, homogenized [OPG study]6.095760
GSM549131patient 030, cancer, homogenized [OPG study]6.0828160
GSM549118patient 074, normal, homogenized [OPG study]6.5207665
GSM549129patient 027, cancer, homogenized [OPG study]6.7901868
GSM549123patient 088, normal, homogenized [OPG study]6.3997664
GSM549124patient 006, cancer, homogenized [OPG study]6.2102261
GSM549126patient 015, cancer, homogenized [OPG study]5.9835558
GSM549128patient 025, cancer, homogenized [OPG study]5.8304855
GSM549103patient 117, normal, homogenized [OPG study]6.3681864
GSM549117patient 073, normal, homogenized [OPG study]5.9867759
GSM549138patient 041, cancer, homogenized [OPG study]6.2441562
GSM549141patient 045, cancer, homogenized [OPG study]6.0248259
GSM549130patient 028, cancer, homogenized [OPG study]6.3949664
GSM549101patient 111, normal, homogenized [OPG study]5.9968658
GSM549105patient 128, normal, homogenized [OPG study]6.2522362
GSM549106patient 134, normal, homogenized [OPG study]5.8554356
GSM549112patient 048, normal, homogenized [OPG study]6.4784765
GSM549125patient 011, cancer, homogenized [OPG study]6.3733264
GSM549127patient 024, cancer, homogenized [OPG study]6.1308259
GSM549135patient 035, cancer, homogenized [OPG study]5.9775758